Anti-Hepatocellular Carcinoma Antibody [CHALV1]

The CHALV1 monoclonal antibody reagent from Antibodies.com is a primary antibody supplied as a 100 µg lyophilised aliquot, intended for research investigations of liver tumors. Produced in mouse and purified as an IgG1 isotype, the unconjugated format gives laboratories full flexibility to pair it with their own secondary detection system, whether chromogenic, fluorescent, or enzymatic, when probing formalin-fixed paraffin-embedded sections or fresh frozen tissue from human donors.

Recognising antigens associated with Hepatocellular Carcinoma, this clone has been cited in immunohistochemistry and immunofluorescence studies that characterise malignant hepatocytes, distinguish HCC from benign lesions, and survey tumor heterogeneity. For reconstitution, the lyophilised pellet is rehydrated with sterile buffer to a working stock; the resulting solution should be stored refrigerated, and aliquots held frozen at -20 °C help preserve activity across longer projects, avoiding repeated freeze-thaw cycles of the original vial.